Variant report

Variant	nsv892847
Chromosome Location	chr9:26134888-26210141
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:208730009..208732803-chr9:26161574..26164201,2	MCF-7	breast:

Extended variants
information (count: 1777 )
Associated
traits (count: 116 )

Variant overlapped rSNPs/rCNVs (count:1777 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7038191	chr9:26134888-26134889	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs557888553	chr9:26134914-26134915	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs115731043	chr9:26134917-26134918	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs537034402	chr9:26134972-26134973	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs565536890	chr9:26134974-26134975	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs75161892	chr9:26134975-26134976	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs551107684	chr9:26135011-26135012	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs571712378	chr9:26135143-26135144	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs181541447	chr9:26135208-26135209	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs530269486	chr9:26135246-26135247	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs16910195	chr9:26135296-26135297	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs73433639	chr9:26135326-26135327	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs186245655	chr9:26135364-26135365	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs546289059	chr9:26135366-26135367	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs74457641	chr9:26135418-26135419	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs76123131	chr9:26135419-26135420	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs191018863	chr9:26135459-26135460	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs538556653	chr9:26135462-26135463	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs557266293	chr9:26135468-26135469	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs78665071	chr9:26135498-26135499	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs536480494	chr9:26135547-26135548	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs555071055	chr9:26135592-26135593	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs184058165	chr9:26135595-26135596	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs148822384	chr9:26135614-26135615	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs187457040	chr9:26135706-26135707	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs373374925	chr9:26135715-26135716	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs577214709	chr9:26135763-26135764	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs544568155	chr9:26135784-26135785	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs573854122	chr9:26135788-26135789	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs562876983	chr9:26135802-26135803	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs530208896	chr9:26135848-26135849	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs34696697	chr9:26135850-26135851	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs371153429	chr9:26135853-26135854	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs560609897	chr9:26135861-26135862	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs375563188	chr9:26135865-26135866	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs137915484	chr9:26135938-26135939	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs571148933	chr9:26135944-26135945	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs532170982	chr9:26135952-26135953	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs550874229	chr9:26136037-26136038	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs569194263	chr9:26136064-26136065	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs536414757	chr9:26136077-26136078	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs554811009	chr9:26136151-26136152	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs191089350	chr9:26136181-26136182	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs534032023	chr9:26136203-26136204	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs10757596	chr9:26136235-26136236	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs577151985	chr9:26136251-26136252	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs544621521	chr9:26136253-26136254	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs554126955	chr9:26136300-26136301	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs182897695	chr9:26136360-26136361	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs574801604	chr9:26136369-26136370	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:116)

Disease	PMID	Source
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Cancer	22183965	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Adenoid cystic carcinoma	18332873	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21858162	CNVD
Pancreatic cancer	21811587	CNVD
Barrett''s syndrome	19417022	CNVD
Myelofibrosis	22110671	CNVD
Urothelial cell carcinoma	18451213	CNVD
polycythaemia	22829968	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:185 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:26130000-26135000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
2	chr9:26133400-26135200	Weak transcription	Adipose Nuclei	Adipose
3	chr9:26134600-26136600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr9:26135000-26135600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
5	chr9:26135200-26136000	Enhancers	Adipose Nuclei	Adipose
6	chr9:26136000-26136400	Weak transcription	Adipose Nuclei	Adipose
7	chr9:26136400-26136600	Enhancers	Adipose Nuclei	Adipose
8	chr9:26136600-26138200	Weak transcription	Adipose Nuclei	Adipose
9	chr9:26137800-26138400	Active TSS	A549	lung
10	chr9:26138200-26138400	Enhancers	Adipose Nuclei	Adipose
11	chr9:26141800-26142200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr9:26144400-26152200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
13	chr9:26145600-26146200	Active TSS	A549	lung
14	chr9:26151400-26151600	Enhancers	HUES6 Cell Line	embryonic stem cell
15	chr9:26151400-26154200	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr9:26151400-26154600	Enhancers	HUES48 Cell Line	embryonic stem cell
17	chr9:26151600-26153400	Enhancers	iPS-18 Cell Line	embryonic stem cell
18	chr9:26151800-26152400	Enhancers	H1 Cell Line	embryonic stem cell
19	chr9:26151800-26152800	Weak transcription	HUES6 Cell Line	embryonic stem cell
20	chr9:26152000-26154000	Enhancers	ES-I3 Cell Line	embryonic stem cell
21	chr9:26152200-26153600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr9:26152200-26153800	Enhancers	iPS-15b Cell Line	embryonic stem cell
23	chr9:26152800-26153600	Enhancers	HUES6 Cell Line	embryonic stem cell
24	chr9:26153000-26153200	Enhancers	iPS-20b Cell Line	embryonic stem cell
25	chr9:26158000-26158200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
26	chr9:26158000-26161800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr9:26158400-26159600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
28	chr9:26158400-26161600	Enhancers	NHDF-Ad	bronchial
29	chr9:26158600-26160200	Enhancers	HSMMtube	muscle
30	chr9:26158600-26160400	Enhancers	Pancreatic Islets	Pancreatic Islet
31	chr9:26159600-26160600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
32	chr9:26159800-26160400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
33	chr9:26160600-26164400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
34	chr9:26161600-26163600	Weak transcription	NHDF-Ad	bronchial
35	chr9:26161800-26163600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr9:26163600-26164400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr9:26163600-26165000	Enhancers	NHDF-Ad	bronchial
38	chr9:26163800-26164600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr9:26164000-26164600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr9:26164200-26164800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
41	chr9:26164400-26164600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr9:26164400-26164800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
43	chr9:26164400-26165200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
44	chr9:26164600-26164800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr9:26164600-26169200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr9:26164600-26169200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr9:26164800-26165000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr9:26164800-26169800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
49	chr9:26165000-26165400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr9:26165400-26167800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links